Header

UZH-Logo

Maintenance Infos

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic


Saunte, D M L; Pereiro‐Ferreirós, M; Rodríguez‐Cerdeira, C; Sergeev, A Y; Arabatzis, M; Prohić, A; Piraccini, B M; Lecerf, P; Nenoff, P; Kotrekhova, L P; Bosshard, P P; Padovese, V; Szepietowski, J C; Sigurgeirsson, B; Nowicki, R J; Schmid-Grendelmeier, P; Hay, R J (2021). Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. Journal of the European Academy of Dermatology and Venerology, 35(7):1582-1586.

Abstract

Background: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.

Objectives: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.

Methods: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.

Results: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.

Conclusions: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.

Abstract

Background: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.

Objectives: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.

Methods: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.

Results: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.

Conclusions: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.

Statistics

Citations

Dimensions.ai Metrics
54 citations in Web of Science®
60 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 28 Apr 2021
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Dermatology
Health Sciences > Infectious Diseases
Uncontrolled Keywords:Infectious Diseases, Dermatology
Language:English
Date:1 July 2021
Deposited On:28 Apr 2021 10:21
Last Modified:25 Jun 2024 01:39
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0926-9959
OA Status:Closed
Publisher DOI:https://doi.org/10.1111/jdv.17241
PubMed ID:33768571